文献速递精神分裂症与精神病性障碍心境障碍

精神病性障碍的遗传风险谱系研究

Profiles of Genetic Risks for Psychotic Disorders.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

这项瑞典全国队列研究纳入1950至2000年出生者,计算精神分裂症、双相障碍和重度抑郁的家族遗传风险评分,发现妄想障碍、急性精神病、未特定精神病和分裂情感障碍从遗传角度看均非精神分裂症、双相障碍或重度抑郁的亚型。

要点

  • 妄想障碍遗传风险独特:精神分裂症遗传风险约为精神分裂症病例的一半,双相障碍和重度抑郁风险相似。
  • 分裂情感障碍是唯一精神分裂症和双相障碍遗传风险均较高的障碍,可与精神病性双相障碍区分。
  • 急性精神病与未特定精神病遗传谱相似:精神分裂症遗传风险与妄想障碍相近,但双相障碍和重度抑郁风险更高。

核心结论

  • 在瑞典人群中,妄想障碍、急性精神病、未特定精神病和分裂情感障碍从遗传角度看均非精神分裂症、双相障碍或重度抑郁的亚型。
  • 这些综合征的进一步遗传学研究有助于理解遗传风险维度与精神病性障碍临床表现及病程的关系。

研究设计与样本

  • 队列研究纳入1950至2000年出生于瑞典且父母为瑞典籍的全部个体,随访至2018年,基于国家登记诊断代码识别重度抑郁、双相障碍、精神分裂症、分裂情感障碍、急性精神病、未特定精神病和妄想障碍。
  • 暴露为基于一至五级亲属计算的精神分裂症、双相障碍和重度抑郁家族遗传风险评分,并控制同居因素。

主要发现

  • 在精神分裂症、双相障碍和重度抑郁家族遗传风险评分构成的遗传图谱上,妄想障碍单独成簇,其精神分裂症遗传风险约为精神分裂症病例的一半,双相障碍和重度抑郁风险水平相似。
  • 按结局细分精神病对妄想障碍遗传图谱影响极小,对急性精神病和未特定精神病影响中等,对分裂情感障碍影响大,良好社会结局与精神分裂症家族遗传风险评分降低和双相障碍家族遗传风险评分升高相关。

临床怎么用

  • 临床评估精神病性障碍时,可将家族遗传风险谱作为辅助信息,理解妄想障碍、急性精神病、未特定精神病和分裂情感障碍与精神分裂症、双相障碍及重度抑郁的遗传区别。
  • 对分裂情感障碍患者,应同时关注精神分裂症和双相障碍的家族遗传风险,其遗传谱与精神病性双相障碍可区分。
  • 急性精神病和未特定精神病患者的精神分裂症遗传风险与妄想障碍相近,但双相障碍和重度抑郁遗传风险更高,提示需关注心境症状维度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The etiologic interrelationship of 4 rare/controversial psychotic disorders (delusional disorder [DD], acute psychoses [AP], psychosis not otherwise specified [PNOS], and schizoaffective disorder [SAD]) is poorly understood. OBJECTIVE: To assess levels of the family genetic risk score (FGRS) for schizophrenia (SZ), bipolar disorder (BD), and major depression (MD) in individuals with DD, AP, PNOS, and SAD, thereby clarifying their genetic relationships. DESIGN, SETTING, AND PARTICIPANTS: This cohort study included all individuals born in Sweden between 1950 and 2000 to Swedish-born parents followed up until 2018 with diagnoses of MD, BD, SZ, SAD, AP, PNOS, and DD, based on diagnosis codes from national registries. EXPOSURES: FGRS for SZ, BD, and MD calculated from first- through fifth-degree relatives, controlling for cohabitation. MAIN OUTCOMES AND MEASURES: Diagnoses of DD, AP, PNOS, and SAD. RESULTS: In the cohort, 667 012 individuals had MD (420 142 females [63%] and 246 870 males [37.0%]), 58 385 had BD (36 344 females [62%] and 22 041 males [38%]), 17 465 had SZ (6330 females [36%] and 11 135 males [64%]), 7597 had SAD (4125 females [54%] and 3472 males [46%]), 16 315 had AP (7907 females [49%] and 8408 males [51%]), 27 127 had PNOS (12 277 females [45%] and 14 850 males [55%]), and 11 560 had DD (5060 females [44%] and 6500 males [56%]). On "genetic maps" of SZ FGRS, BD FGRS, and MD FGRS, DD stood alone with approximately half the genetic risk for SZ compared with SZ cases and similar levels of BD and MD risk. SAD was also distinct as the only disorder with quite high genetic risks for both SZ and BD and was clearly separable from psychotic BD. AP and PNOS had similar genetic profiles with levels of SZ FGRS similar to DD but higher levels of genetic risk for BD and MD. Subdividing psychoses by outcome produced minimal effects on the DD genetic profile, moderate effects on AP and PNOS, and large effects on SAD, with good social outcomes associated with decreased SZ FGRS and increased BD FGRS. CONCLUSIONS AND RELEVANCE: In a Swedish population, none of the 4 disorders appeared, from a genetic perspective, to be subtypes of SZ, BD, or MD. Further genetics research on the syndromes of DD, AP, PNOS, and SAD have much to teach about the relationship between dimensions of genetic risks and the clinical presentation and course of psychotic illness.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kendler KS, Ohlsson H, Sundquist J, et al. Profiles of Genetic Risks for Psychotic Disorders. JAMA Psychiatry. 2025. PMID: 40632548. doi:10.1001/jamapsychiatry.2025.1289

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。